Science Daily·3 min read·medium
The Ozempic and Wegovy mistake sending thousands to poison control
✦AI Summary
Researchers are investigating a significant rise in poison control center calls related to semaglutide, the active ingredient in weight-loss drugs like Ozempic and Wegovy. The study suggests that the surge in calls may be linked to the drug's rapid popularity and potential misuse following its FDA approval for weight management.
The explosive growth in semaglutide (Ozempic and Wegovy) We use after its FDA approval for chronic weight management in 2021 was accompanied by another trend that drew researchers' attention: a dramatic increase in calls to poison control centers across the United States.
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in